Covid-19 Pandemic
 Here’s the latest news from the global pandemic. Merkel urges EU to agree on recovery fund U.K. manufacturers warn of layoffs, plead for investmentFauci says coronavirus mutation may speed spread China’s leader in the vaccine chase With China and Canada at geopolitical odds over a range of issues, it may come as a surprise that one of the front-runners in the race for a coronavirus vaccine is born of their combined biotech prowess. Add the fact that this same vaccine is backed by a superstar general in the Chinese military, and it’s easy to see why Tianjin-based CanSino Biologics Inc.’s immunization is being watched closely as a potential way to halt the accelerating pandemic. One among a handful of Chinese companies whose vaccines have reached the crucial final stage of human testing, CanSino has also received scientific kudos for publishing the full data from the first phase of its human trials in the Lancet medical journal. Other front-runner vaccine makers, including major western efforts, have only released selected data points and positive press releases to the public. In reporting on the origins of the intriguing company, I’ve found that CanSino’s story is also that of China’s burgeoning biotech sector as a whole, which had been making leaps and bounds in progress even before the pandemic. Chinese President Xi Jinping’s vow to provide Chinese vaccines equitably to the whole world shows how high the pressure is on its scientists to prove themselves in this crisis.  Chinese President Xi Jinping has made creating a Covid-19 vaccine a priority. Photographer: Xinhua News Agency/Xinhua News Agency The rise of China’s biotech and medical science sector is buoyed by people like CanSino’s founders, talented China-born scientists who trained and worked in Canada for decades before returning home to make their own fortunes and names. (The “Can” in CanSino refers to the North American country.) Their strong network there paid off in approval from Canada’s health authorities to allow testing and manufacture of its vaccine locally. Sometime in the late 2000s, CanSino’s founders gathered at a backyard in Toronto on a hot summer day over barbecue and beers, talking about the glaring gap between the motherland and the developed world in vaccine-making. They made it a mission of their own to close that gap. Now they’re closer than ever.—Lyu Dong Tracking the virus When Will the Virus Peak in Each U.S. State? As the nation heads into the Fourth of July holiday, officials urged citizens to stay home to mitigate the impact of the pandemic. The latest projections include the possibility of a second wave of deaths, with as many as 199,000 deaths by October.  Save the date: Join us on July 6 at 3 p.m. BST/10 a.m. EDT for an exclusive virtual EU Policy Series briefing with Bruno Le Maire, French Minister of Finance and Economy, with Francine Lacqua. The minister will discuss the economic impact of the Covid-19 crisis on the European economy, as well as his view on the French government’s action to contain the economic fallout. Get details and register here. What you should read Pandemic Doubts Haunt Europe’s Path to Growth Quarterly pace of economic contraction slowed to 0.2% in June. Why Americans Wear Face Masks. Or Not. Partisan, generational and geographic differences all come into play. Lobster-Town U.S.A. Feels Pandemic Pinch Pain of the suffering industry ripples throughout a community. Pandemic Evictions Will Wipe Out Black Renters Boston study shows impact of ‘tsunami of evictions.’ Trump Says U.S. Economy Is Roaring Back Some states slow reopening of economies as virus cases spike. Know someone else who would like this newsletter? Have them sign up here. Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story. Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close. Follow Us Get the newsletter You received this message because you are subscribed to Bloomberg’s Coronavirus Daily newsletter. Unsubscribe | Bloomberg.com | Contact Us Bloomberg L.P. 731 Lexington, New York, NY, 10022 |
PreviousHighway Funding